Refractory High Risk Myelodysplastic Syndrome

Explore clinical trials studying Refractory High Risk Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Refractory High Risk Myelodysplastic Syndrome trial results

Recruiting

NCT04047641

Conditions: Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, Hematologic Diseases, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Recruiting

NCT03896269

Conditions: Blasts 10-19 Percent of Bone Marrow Nucleated Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Bone Marrow Diseases, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Recruiting

NCT03383575

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +22 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

Cleveland Clinic Foundation Cleveland, Ohio, United States

M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT03359460

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Completed

NCT02649764

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT02921061

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States